Children’s Oncology Hospital Units utilise TAP’s Fill-It System for Immunotherapy Research To Determine Optimal Dose of Cancer Therapies and Create Stocks of Consistent, High Quality Product for Clinical Trials
TAP Biosystems
02/04/2014Cambridge, UK: TAP Biosystems, (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture systems and consumables for life science applications, today announced its Fill-It™, automated cryovial filling system is being routinely used in clinical trials of novel cell-based cancer immunotherapies at children’s oncology units in three major US hospitals. The system is being utilised in research labs to help determine the correct...